SCHEMBL27678972

SCHEMBL27678972

NC(CC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)O)C(=O)O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACE P12821 4/20 0.69
▸ KDM4E B2RXH2 1/20 0.68
▸ MEN1 O00255 1/20 0.68
▸ LMNA P02545 1/20 0.68
▸ MPO P05164 1/20 0.68
▸ MAPT P10636 1/20 0.68
▸ TSHR P16473 1/20 0.68
▸ BLM P54132 1/20 0.68
▸ PMP22 Q01453 1/20 0.68
▸ KMT2A Q03164 1/20 0.68
▸ HIF1A Q16665 1/20 0.68
▸ ERAP2 Q6P179 2/20 0.64
▸ ALOX15 P16050 1/20 0.64
▸ ITGB2 P05107 5/20 0.62
▸ ICAM1 P05362 5/20 0.62
▸ ITGAL P20701 5/20 0.62
▸ LTA4H P09960 1/20 0.61
▸ ECE1 P42892 1/20 0.61
▸ P2RY14 Q15391 1/20 0.61
▸ TP53 P04637 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL728052 1.00 ACE (0.69) ACEKDM4EMEN1LMNAMPO
SCHEMBL8529176 1.00 ACE (0.69) ACEKDM4EMEN1LMNAMPO
SCHEMBL1782890 1.00 ACE (0.69) ACEKDM4EMEN1LMNAMPO
SCHEMBL16855056 0.89 KDM4E (0.60) ACEKDM4EMEN1LMNAMPO
SCHEMBL16855202 0.89 KDM4E (0.60) ACEKDM4EMEN1LMNAMPO
Golotimod SCHEMBL12818886 0.88 KDM4E (0.65) ACEKDM4EMEN1LMNAMPO
Golotimod SCHEMBL726938 0.88 KDM4E (0.65) ACEKDM4EMEN1LMNAMPO
Orilotimod SCHEMBL29379690 0.88 KDM4E (0.65) ACEKDM4EMEN1LMNAMPO
Golotimod SCHEMBL726291 0.88 KDM4E (0.65) ACEKDM4EMEN1LMNAMPO
Golotimod SCHEMBL29622906 0.88 KDM4E (0.65) ACEKDM4EMEN1LMNAMPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101842009-A Treatment of lung cancer SCICLONE PHARMACEUTICALS INC 2010-09-22 — — CN disclosed
CN-101678069-A Treatment of allergic disease with immunomodulator compounds SCICLONE PHARMACEUTICALS INC 2010-03-24 — — CN disclosed
CN-101657210-A Method of treating or preventing tissue deterioration, injury or damage due to disease of mucosa SCICLONE PHARMACEUTICALS INC U 2010-02-24 — — CN disclosed
CN-101448514-A Treatment of melanoma SCICLONE PHARMACEUTICALS INC (US) 2009-06-03 — — CN disclosed
CN-1964731-A Treatment or prevention of respiratory tract pathogenic infection with immunomodulator compounds SCICLONE PHARMACEUTICALS INC (US) 2007-05-16 — — CN disclosed
Send feedback